BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 17891366)

  • 1. Pericytes: gatekeepers in tumour cell metastasis?
    Gerhardt H; Semb H
    J Mol Med (Berl); 2008 Feb; 86(2):135-44. PubMed ID: 17891366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The great escape; the hallmarks of resistance to antiangiogenic therapy.
    van Beijnum JR; Nowak-Sliwinska P; Huijbers EJ; Thijssen VL; Griffioen AW
    Pharmacol Rev; 2015; 67(2):441-61. PubMed ID: 25769965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis.
    Hosaka K; Yang Y; Seki T; Nakamura M; Andersson P; Rouhi P; Yang X; Jensen L; Lim S; Feng N; Xue Y; Li X; Larsson O; Ohhashi T; Cao Y
    Nat Commun; 2013; 4():2129. PubMed ID: 23831851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
    Raza A; Franklin MJ; Dudek AZ
    Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
    Virgintino D; Ozerdem U; Girolamo F; Roncali L; Stallcup WB; Perris R
    J Vasc Res; 2008; 45(2):129-31. PubMed ID: 17943023
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour angiogenesis-Origin of blood vessels.
    Krishna Priya S; Nagare RP; Sneha VS; Sidhanth C; Bindhya S; Manasa P; Ganesan TS
    Int J Cancer; 2016 Aug; 139(4):729-35. PubMed ID: 26934471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth.
    Lechertier T; Reynolds LE; Kim H; Pedrosa AR; Gómez-Escudero J; Muñoz-Félix JM; Batista S; Dukinfield M; Demircioglu F; Wong PP; Matchett KP; Henderson NC; D'Amico G; Parsons M; Harwood C; Meier P; Hodivala-Dilke KM
    Nat Commun; 2020 Jun; 11(1):2810. PubMed ID: 32499572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenesis and metastasis: a tumour and stromal cell alliance.
    Moserle L; Casanovas O
    J Intern Med; 2013 Feb; 273(2):128-37. PubMed ID: 23198797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-Endothelial Cell Communications: Important and Indispensable Mediators of Tumour Angiogenesis.
    Lopes-Bastos BM; Jiang WG; Cai J
    Anticancer Res; 2016 Mar; 36(3):1119-26. PubMed ID: 26977007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
    Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Proteolytically Driven Tumor Lymphangiogenesis.
    Lolas G; Jensen L; Bourantas GC; Tsikourkitoudi V; Syrigos K
    Adv Exp Med Biol; 2016; 936():107-136. PubMed ID: 27739045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor vasculature: a sally port for inhibiting cancer cell spreading.
    Qian CN; Pezzella F
    Cancer Commun (Lond); 2018 Aug; 38(1):52. PubMed ID: 30075743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.
    Shenoy AK; Lu J
    Cancer Lett; 2016 Oct; 380(2):534-544. PubMed ID: 25449784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
    Welén K; Jennbacken K; Tesan T; Damber JE
    Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peril in perishing pericytes.
    Péault B
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26296363
    [No Abstract]   [Full Text] [Related]  

  • 17. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes that regulate metastasis and angiogenesis.
    Webb CP; Vande Woude GF
    J Neurooncol; 2000; 50(1-2):71-87. PubMed ID: 11245283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of pericyte α6β1-integrin in tumour blood vessels.
    Reynolds LE; D'Amico G; Lechertier T; Papachristodoulou A; Muñoz-Félix JM; De Arcangelis A; Baker M; Serrels B; Hodivala-Dilke KM
    J Cell Sci; 2017 May; 130(9):1583-1595. PubMed ID: 28289267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericytes: a double-edged sword in cancer therapy.
    Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
    Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.